Stay updated with breaking news from கெவின் கசப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article CAMBRIDGE, Mass., March 16, 2021 /PRNewswire/ Remix Therapeutics, a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the underlying drivers of disease, today announced the appointment of Matthew R. Patterson as Executive Chairman of the company s Board of Directors. Mr. Patterson is the co-founder and former chairman and CEO of Audentes Therapeutics, a gene therapy company acquired by Astellas Pharma in 2020. Matt has had an impressive 30-year career in research, drug development, and the commercialization of innovative therapeutics for both private and publicly held biotechnology companies, said Kevin Bitterman, PhD, Founding Chairman of the Board of Remix Therapeutics and Partner at Atlas Venture. His knowledge of the industry and experience building and advancing early-stage companies will be invaluable as we shape the path forward for Remix. ....